Gene · 5600
Papers1,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| p38 Mitogen-Activated Protein Kinase Inhibition of Mesenchymal Transdifferentiated Tumor Cells in Head and Neck Squamous Cell Carcinoma. | Biomedicines | 2023 | 38137525 | PubTator, text mining | PubMed |
| Mir-142-3P regulates MAPK protein family by inhibiting 14-3-3η to enhance bone marrow mesenchymal stem cells osteogenesis. | Sci Rep | 2023 | 38129425 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| Effects of Coverlys TF150® on the Photosynthetic Characteristics of Grape. | Int J Mol Sci | 2023 | 38068982 | PubTator, text mining | PubMed |
| Retraction: The Rational Design of Specific Peptide Inhibitor against p38α MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC. | PLoS One | 2023 | 38064484 | PubTator, text mining | PubMed |
| JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer's disease. | Nat Commun | 2023 | 38049398 | PubTator, text mining | PubMed |
| Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting. | Elife | 2023 | 38047771 | PubTator, text mining | PubMed |
| Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38α. | Nat Commun | 2023 | 38040726 | PubTator, text mining | PubMed |
| Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines. | Heliyon | 2023 | 38034665 | PubTator, text mining | PubMed |
| The Essential Oil from Conyza bonariensis (L.) Cronquist (Asteraceae) Exerts an In Vitro Antimelanoma Effect by Inducing Apoptosis and Modulating the MAPKs, NF-κB, and PKB/AKT Signaling Pathways. | Pharmaceuticals (Basel) | 2023 | 38004419 | PubTator, text mining | PubMed |
| Role of the p38/AKT Pathway in the Promotion of Cell Proliferation by Serum Heat Inactivation. | Int J Mol Sci | 2023 | 38003726 | PubTator, text mining | PubMed |
| A Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Pharmacological Mechanism of Astragalus membranaceus for Glioma. | Int J Mol Sci | 2023 | 38003496 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Directed Reprogramming of iPSC for Accelerated Motor Neuron Differentiation Leads to Dysregulation of Neuronal Fate Patterning and Function. | Int J Mol Sci | 2023 | 38003351 | PubTator, text mining | PubMed |
| Novel Biomarkers and Advanced Cardiac Imaging in Aortic Stenosis: Old and New. | Biomolecules | 2023 | 38002343 | PubTator, text mining | PubMed |
| Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease. | Biomolecules | 2023 | 38002302 | PubTator, text mining | PubMed |
| Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment. | Cancers (Basel) | 2023 | 38001572 | PubTator, text mining | PubMed |
| Global research trends of infantile hemangioma: A bibliometric and visualization analysis from 2000 to 2022. | Heliyon | 2023 | 37920523 | PubTator, text mining | PubMed |
| Exploring the mechanism of resistance to vincristine in breast cancer cells using transcriptome sequencing technology. | Oncol Lett | 2023 | 37920438 | PubTator, text mining | PubMed |
| p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. | Cell Commun Signal | 2023 | 37919729 | PubTator, text mining | PubMed |
| Association of Promoter Methylation Patterns with Expression of MAPK14 in Tissue of Papillary Thyroid Cancer Patients. | Asian Pac J Cancer Prev | 2023 | 37898857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5600/papers?page=4